130 abstracts found.



GvHD: uncoupling immunopathology from the graft-vs-leukemia effect.

Year:

Session type:

Theme:

Burkhard Becher1
1University of Zurich

Identifying and interpreting robust genetic dependencies in cancer cell lines

Year:

Session type:

Theme:

Colm Ryan1
1University College Dublin

Discovery of first-in class, selective and noncovalent small molecule inhibitors of DNMT1

Year:

Session type:

Theme:

Allan Jordan1
1CRUK Manchester Institute

The challenges of rare cancer: Time for change

Year:

Session type:

Theme:

Richard Adams1
1Cardiff University

Precision oncology

Year:

Session type:

Theme:

Sandesh Kc1,Thomas King2,David Mak2,Rupesh Bhatt2,Alan Doherty2,Richard Viney2,Prashant Patel2,Brian Kelly2

1University Hospital Birmingham,2UHB

A personalised approach to treating patients with haematological malignancies

Year:

Session type:

Theme:

Susanne Saussele1
1Universitätsmedizin Mannheim

Applying genomics to tailor colorectal cancer screening in primary care

Year:

Session type:

Theme:

Jon Emery1
1Centre for Cancer Research and Department of General Practice, University of Melbourne

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial

Year:

Session type:

Theme:

Richard Martin1
1University of Bristol

Designing trials in smaller populations

Year:

Session type:

Theme:

Matthew Sydes1
1MRC Clinical Trials Unit at UCL

Molecular archaeology of cancer

Year:

Session type:

Theme:

Peter Van Loo1,2

1The Francis Crick Institute, London, UK,2University of Leuven, Leuven, Belgium

Molecular Imaging of Immunotherapies

Year:

Session type:

Theme:

Sanjiv Gambhir1
1Stanford university

Clone Wars in Leukaemia: Are there lessons for all cancers?

Year:

Session type:

Theme:

Paresh Vyas1
1University of Oxford

New approaches in the diagnosis of lung cancer – from bench to primary care

Year:

Session type:

Theme:

Richard Neal1
1University of Leeds

Methodological issues in precision oncology trials

Year:

Session type:

Theme:

Lucinda Billingham1
1Cancer Research UK Clinical Trials Unit, University of Birmingham

Core Outcomes Sets for trials and Core Information Sets for consultations: keeping them patient centred

Year:

Session type:

Theme:

Jane Blazeby1,Angus McNair1
1University of Bristol

Applying genetic information to prevent colorectal cancer

Year:

Session type:

Theme:

Malcolm Dunlop1
1University of Esinburgh

Tumor-educated platelets for the detection and monitoring of cancer

Year:

Session type:

Theme:

Thomas Wurdinger1
1VU University Medical Center

Intra-operative Electron beam radiotherapy for advanced and recurrent abdominopelvic malignancies in the UK: Development, implementation, and medium term results

Year:

Session type:

Theme:

Alex Mirnezami1
1University of Southampton

Computational Pathology: Challenges and Opportunities

Year:

Session type:

Theme:

Nasir Rajpoot1
1University of Warwick

Best practices for integration of Patient-Reported Outcomes (PROs) into trials

Year:

Session type:

Theme:

Derek Kyte1
1University of Birmingham

Co-existing Tumour-Immune Microenvironments in Advanced Ovarian Cancer

Year:

Session type:

Theme:

Martin Miller1
1University of Cambridge

Use and safety of novel alternative nicotine delivery devices: a role for cancer harm reduction?

Year:

Session type:

Theme:

Lion Shahab1
1University College London

Surgery-dependent Translational Research

Year:

Session type:

Theme:

Richard Shaw1
1NIHR Cancer Research Network (NCRN)

Digital Pathology & Artificial Intelligence, the Third Revolution in Pathology

Year:

Session type:

Theme:

Manuel Salto-Tellez1
1Queen's University Belfast

Adipocytes in the melanoma microenvironment

Year:

Session type:

Theme:

Richard White1
1Memorial Sloan-Kettering Cancer Center

Air pollution and cancer

Year:

Session type:

Theme:

John Cherrie1
1Heriot Watt University and the Institute of Occupational Medicine

Lung Cancer IO – hi ho

Year:

Session type:

Theme:

Mary O'Brien1
1Royal Marsden NHS Hospital

Inhibition of the pro-tumorigenic effects of TGFbeta in tumor therapy

Year:

Session type:

Theme:

Carl-Henrik Heldin1
1Uppsala University

Precision medicine for melanoma: are we there yet?

Year:

Session type:

Theme:

Richard Marais1
1CR-UK Manchester Institute

Carbon Nanotubes may pose Asbestos-style Cancer Risk

Year:

Session type:

Theme:

Marion MacFarlane1
1MRC Toxicology Unit, University of Cambridge

Challenges in Managing the Immune Related Toxicities of Cancer Immunotherapy

Year:

Session type:

Theme:

Paul Nathan1
1Mount Vernon Hospital

Deregulated TGF-β signalling in cancer

Year:

Session type:

Theme:

Caroline Hill1
1The Francis Crick Institute

Options and Opportunities for Health Data Science

Year:

Session type:

Theme:

Andrew Morris1
1Health Data Research UK

Circulating tumour DNA as a tool to guide clinical decision making in melanoma

Year:

Session type:

Theme:

Rebecca Lee1
1CRUK MI

Surviving the Cure: Blood and Marrow Transplantation as Model For Cancer Survivorship

Year:

Session type:

Theme:

Navneet Majhail1
1Cleveland Clinic

Role of TGF-beta in glioblastoma

Year:

Session type:

Theme:

Joan Seoane1
1Vall d'Hebron University Hospital

Mining genomic data to inform cancer prevention &  treatment strategies

Year:

Session type:

Theme:

Richard Martin1
1University of Bristol

From rarity to clarity: gd T cells in cancer

Year:

Session type:

Theme:

Seth Coffelt1
1Beatson Institute for Cancer Research

Identification of novel therapeutic targets for triple negative breast cancer through integrative kinomics

Year:

Session type:

Theme:

Roger Daly1
1Department of Biochemistry and Molecular Biology, Monash University

Role of the gut microbiome in causing, detecting and treating coloretal cancer.

Year:

Session type:

Theme:

Paul O'Toole1
1School of Microbiology and APC Microbiome Inst

Multimorbidity in primary care: implications for cancer prevention, diagnosis and support

Year:

Session type:

Theme:

David Blane1
1University of Glasgow

Antibody Tumour Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

Year:

Session type:

Theme:

Sean Lim1
1University of Southampton

Pancreatic Cancer Immunotherapy: From Bench to Bedside

Year:

Session type:

Theme:

George Miller1
1New York University School of Medicine

Impact of patient’s gut microbiome on clinical reponse to cancer immunotherapy

Year:

Session type:

Theme:

Robert Jenq1
1University of Texas MD Anderson Cancer Center

Understanding the role of multimorbidity on symptomatic presentation and early diagnosis of cancer

Year:

Session type:

Theme:

Katriina Whitaker1
1University of Surrey

Identifying the early cancerous body

Year:

Session type:

Theme:

Rikke Sand Anderson1
1Aarhus University

Heterocellular interactions in the tumour microenvironment

Year:

Session type:

Theme:

Claus Jorgensen1
1CRUK Manchester Institute

The burden of cancer due to inequalities and its likely causes – Introduction

Year:

Session type:

Theme:

Yoryos Lyratzopoulos1
1University College London

NHS Cancer Strategy

Year:

Session type:

Theme:

David Fitzgerald1
1NHS England

Exploring genomic medicine at the interface of cancer research and clinical care

Year:

Session type:

Theme:

Anne Kerr1
1University of Leeds